Rhythm Pharmaceuticals Wins Japan Approval for IMCIVREE
BOSTON, August 24, 2026 Rhythm Pharmaceuticals, Inc. announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has granted...
Japan
Advertisement
Pharming Launches Joenja in Japan for APDS Patients
LEIDEN, Netherlands, August 13, 2026 Pharming Group N.V. announced the commercial launch of Joenja® (leniolisib) in Japan for adults...
Bracco Gains FDA Clearance for VueJect Cardiac Imaging System
MILAN, Italy, August 11, 2026 Bracco Imaging has announced that its VueJect® ultrasound contrast delivery system has received 510(k)...
Alfasigma to Acquire Nordic Pharma in European M&A Deal
BOLOGNA AND MILAN, Italy, August 13, 2026 Alfasigma S.p.A. has entered into a share purchase agreement with SEVER Life...
Natera Submits Signatera to Japan PMDA for MIBC Approval
AUSTIN, Texas, August 5, 2026 Natera, Inc. has submitted an application to Japan’s Pharmaceuticals and Medical Devices Agency (PMDA)...
Advertisements
Galderma Launches Alastin in Japan and Asia Pacific to Expand Regenerative Skincare Portfolio
Zug, Switzerland | July 20, 2026 Galderma announced the expansion of its Alastin® regenerative skincare brand across the Japan...
Telix Completes Phase 3 Enrollment for Illuccix in Japan
MELBOURNE, Australia, and TOKYO, Japan, July 17, 2026 Telix Pharmaceuticals has completed patient enrollment in its pivotal Phase 3...
Sanofi Wins Japan Approval for Sarclisa SC in Myeloma
PARIS | June 19, 2026 Sanofi announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved the...
Italfarmaco–JCR Givinostat Deal Expands Rare Disease Pharma in Japan
MILAN, Italy & HYOGO, Japan | December 24, 2025 — Italfarmaco and JCR Pharmaceuticals have announced a landmark commercialisation...
Advertisement
